Inflation rebates to reduce Medicare payment for 34 Part B drugs

Description

This October through December under the Inflation Reduction Act, Medicare will reduce the beneficiary coinsurance amount for 34 Part B prescription drugs between $1 and $618 per average dose, the Centers for Medicare & Medicaid Services announced recently.

News Academic Progression

Pharmacy, Free Full-Text

Costs of 34 Medicare Drugs Capped at $618 Until December

CMS Requiring All 340B Entities to Use Claims Modifiers When

Chart: The Ever-Increasing Cost of Medicare Drugs

The Inflation Reduction Act: A tale of two drugs - Putnam

Feds Share Details on Inflation Rebates for Medicare Prescription

News ASHRM

Medicare Prescription Drug Rebate Rule

$ 8.00USD
Score 5(243)
In stock
Continue to book